↓ Skip to main content

Thymectomy for non‐thymomatous myasthenia gravis

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

wikipedia
2 Wikipedia pages

Readers on

mendeley
135 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thymectomy for non‐thymomatous myasthenia gravis
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd008111.pub2
Pubmed ID
Authors

Gabriel Cea, Michael Benatar, Renato J Verdugo, Rodrigo A Salinas

Abstract

Treatments currently used for patients with myasthenia gravis (MG) include steroids, non-steroid immune suppressive agents, plasma exchange, intravenous immunoglobulin and thymectomy. Data from randomized controlled trials (RCTs) support the use of some of these therapeutic modalities and the evidence for non-surgical therapies are the subject of other Cochrane reviews. Significant uncertainty and variation persist in clinical practice regarding the potential role of thymectomy in the treatment of people with MG.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Poland 1 <1%
Unknown 133 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 13%
Student > Master 14 10%
Other 13 10%
Student > Postgraduate 11 8%
Researcher 10 7%
Other 33 24%
Unknown 37 27%
Readers by discipline Count As %
Medicine and Dentistry 62 46%
Nursing and Health Professions 11 8%
Neuroscience 6 4%
Biochemistry, Genetics and Molecular Biology 5 4%
Agricultural and Biological Sciences 2 1%
Other 11 8%
Unknown 38 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2020.
All research outputs
#8,738,637
of 25,870,940 outputs
Outputs from Cochrane database of systematic reviews
#9,724
of 13,151 outputs
Outputs of similar age
#76,985
of 225,373 outputs
Outputs of similar age from Cochrane database of systematic reviews
#163
of 216 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,373 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.